Cardiology
Conference Coverage
Vintage drug atop IV loop diuretics boosts decongestion in ADHF: ADVOR
Adding the IV drug to loop diuretics in the ADVOR trial improved decongestion success in volume-overloaded patients with acute decompensated heart...
Conference Coverage
Dapagliflozin’s HFpEF benefit recasts heart failure treatment: DELIVER
Results from DELIVER made dapagliflozin the third SGLT2 inhibitor to benefit patients with HFpEF, cementing a new, ejection fraction–agnostic...
Conference Coverage
TIME: CV events similar with evening or morning dose of BP meds
Despite a suggestion that evening dosing may be better, patients who took antihypertensive medication either evening or morning had similar...
Conference Coverage
Sacubitril/valsartan shows cognitive safety in heart failure: PERSPECTIVE
Patients with heart failure on sacubitril/valsartan had no signal of cognitive decline, compared with controls in PERSPECTIVE, a prospective,...
Conference Coverage
Secondary CV prevention benefit from polypill promises global health benefit
In older patients with a prior myocardial infarction, a three-drug polypill significantly reduced risk of CV events in the multinational SECURE...
News
Congressman’s wife died after taking herbal remedy marketed for diabetes and weight loss
Lori McClintock’s death was caused by “adverse effects of white mulberry leaf ingestion,” according to the coroner’s report.
News
Early menopause linked with increased risk of heart problems
A study of more than 1.4 million women revealed that the younger the age at menopause, the higher the risk of heart failure and atrial...
Conference Coverage
NSAIDs linked to heart failure risk in diabetes
A Danish case-crossover study found that NSAID use increased heart failure risks 50% in patients with diabetes.
News
Low-dose edoxaban curbs stroke risk in elderly with AF, despite frailty
A subanalysis of ELDERCARE-AF suggests a very low 15-mg dose of edoxaban safely reduces stroke and systemic embolism in elderly patients with AF...
News
‘Conservative’ USPSTF primary prevention statin guidance finalized
The new statement invites comparison with the more comprehensive 2018 ACC/AHA-multisociety statin guidelines. A slew of editorials across several...